Oxaliplatin 00955-1733-20
- Manufacturer
- Winthrop U.s, A Business Of Sanofi-Aventis U.s. Llc
- Dosage Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 1, 2015
- Listing Expires
- December 31, 2026
- Application
- NDA021759
Need to source Oxaliplatin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Oxaliplatin | 5 mg/mL |
Drug Class
Platinum-based Drug [EPC]Platinum-based Drug [EPC]Platinum-containing Compounds [EXT]
Selected Package
00955-1733-20Selected1 VIAL, GLASS in 1 CARTON (0955-1733-20) / 20 mL in 1 VIAL, GLASS